AYM Syntex Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
AYMSYNTEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AYM Syntex has filed a quarterly compliance statement confirming that there has been no deviation or variation in the use of funds raised through a preferential issue of equity shares conducted on October 29, 2024. The company raised Rs. 141.76 crore in total, with the original allocation split across four purposes: Rs. 59 crore for capital expenditure, Rs. 33.76 crore for general corporate purposes, Rs. 25 crore for reduction of working capital borrowings, and Rs. 24 crore for repayment of other debt. The statement, reviewed by the Audit Committee on February 13, 2026, confirms full utilization of funds as per the originally disclosed objects. The monitoring agency for the issue is CARE Ratings Limited, and both the Audit Committee and auditors had no comments on the report.
This is a routine regulatory disclosure indicating that the company has deployed the Rs. 141.76 crore raised from the preferential issue entirely in line with what was originally promised to shareholders, which is a positive signal of governance and fund-management discipline. No negative impact on shareholders; the filing merely confirms accountability and transparency.